ArticleRheumatology international2026
Diagnostic performance of Prof. Valmed, ChatGPT-5 Thinking, and OpenEvidence in rheumatology: A comparative evaluation.
Article in Rheumatology international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Development and Nationwide Multicentre Evaluation of Guideline-Grounded Large Language Model Chatbots to Support Patient Self-Management and Education in Rheumatology.Journal of medical systems · 2026Article
- Large language models show high clinical safety but differences in completeness for reproductive counselling in women with inflammatory rheumatic and musculoskeletal diseases: a comparative expert evaluation.Rheumatology international · 2026Article
- Evaluating the First CE-Marked LLM-Based Chatbot for Evidence-Based Neurology.European journal of neurology · 2026Article
- Moderate-to-substantial agreement of ChatGPT-5 for Kellgren-Lawrence grading on synthetic knee radiographs: a controlled cross-sectional observer agreement study.Rheumatology international · 2026Article
- A patient-derived benchmark for evaluating large language models in connective tissue diseases: blinded multi-stakeholder assessment and guideline comparison.Rheumatology international · 2026Observational
- Assessment of CDASI scoring by a multimodal large language model: a comparative study with expert assessors.Rheumatology international · 2026Article
- AI-enabled clinical decision support in breast cancer care: a blinded multicenter benchmarking study comparing medically specialized with a general-purpose system.Journal of medical systems · 2026Article
- Artificial stupidity or logimorphism? How misuse of language warps our thinking about 'artificial intelligence'.European heart journal. Digital health · 2026Article
- [Large language models in rheumatology : New ways of knowledge transfer].Zeitschrift fur Rheumatologie · 2026Review
- A review for navigating the trade-offs: evaluating open-source and proprietary large language models for clinical and biomedical information extraction.Frontiers in digital health · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To compare the diagnostic performance of a subscription-based medical large language model (LLM) certified as a medical device (Prof. Valmed), a subscription-based general-purpose LLM (ChatGPT-5 Thinking), and a freely accessible medical LLM (OpenEvidence). Sixty vignettes covering rare rheumatic diseases and differential diagnoses were entered using a standardized prompt to generate five top diagnoses and respective diagnostic probabilities. Blinded rheumatologists categorized suggested diagnoses as identical, plausible, or diagnostically different. Diagnostic accuracy was assessed using proportions of identical and plausible diagnoses and a total diagnostic score. Analyses were descriptive. Group differences for the proportion of identical top diagnoses were explored using Cochran’s Q test and post-hoc McNemar tests. Processing time was recorded. OpenEvidence produced the highest proportion of identical top diagnoses (35.0%), followed by ChatGPT-5 Thinking (26.7%) and Prof. Valmed (23.3%); however, pairwise differences were not statistically significant. ChatGPT-5 Thinking achieved the highest total diagnostic score (226), followed by OpenEvidence (221) and Prof. Valmed (212). All systems showed markedly higher diagnostic probabilities for identical versus different diagnoses. Mean processing times ranged from 20 to 36 s. All three systems demonstrated broadly comparable diagnostic accuracy and processing times. Further benchmarking that incorporates additional evaluation dimensions is essential to inform safe and effective use of LLM-based clinical support.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.